• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马垂体中间叶功能障碍:澳大利亚和新西兰马内分泌组的当前认识与建议

Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group.

作者信息

Secombe C J, Bailey S R, de Laat M A, Hughes K J, Stewart A J, Sonis J M, Tan Rhh

机构信息

College of Veterinary Medicine, School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, Australia.

Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Werribee, VIC, Australia.

出版信息

Aust Vet J. 2018 Jul;96(7):233-242. doi: 10.1111/avj.12716. Epub 2018 Jun 3.

DOI:10.1111/avj.12716
PMID:29862508
Abstract

The purpose of this article is to provide a review of the current knowledge and opinions about the epidemiology, clinical findings (including sequelae), diagnosis, treatment and monitoring of equine pituitary pars intermedia dysfunction, particularly in the Australian context. This information and the recommendations provided will assist practitioners in making informed decisions regarding the diagnosis and management of this disorder.

摘要

本文旨在综述有关马垂体中间叶功能障碍的流行病学、临床发现(包括后遗症)、诊断、治疗及监测的当前知识和观点,特别是在澳大利亚背景下的情况。所提供的这些信息和建议将有助于从业者在对该疾病进行诊断和管理时做出明智的决策。

相似文献

1
Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group.马垂体中间叶功能障碍:澳大利亚和新西兰马内分泌组的当前认识与建议
Aust Vet J. 2018 Jul;96(7):233-242. doi: 10.1111/avj.12716. Epub 2018 Jun 3.
2
Case series of equine pituitary pars intermedia dysfunction in a tropical climate.热带气候下马垂体中间部功能障碍的病例系列
Aust Vet J. 2012 Nov;90(11):451-6. doi: 10.1111/j.1751-0813.2012.00997.x. Epub 2012 Oct 11.
3
BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.BEVA初级保健临床指南:马垂体中间叶功能障碍的诊断与管理
Equine Vet J. 2024 Mar;56(2):220-242. doi: 10.1111/evj.14009. Epub 2023 Oct 5.
4
Equine pituitary pars intermedia dysfunction.马垂体中间部功能障碍
Vet Clin North Am Equine Pract. 2011 Apr;27(1):93-113. doi: 10.1016/j.cveq.2010.12.007.
5
Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.用于诊断马垂体中间部功能障碍的促肾上腺皮质激素单次及配对测量研究
J Vet Intern Med. 2015 Jan;29(1):355-61. doi: 10.1111/jvim.12489. Epub 2014 Oct 13.
6
Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.使用培高利特恢复中间部垂体多巴胺浓度和酪氨酸羟化酶表达水平:来自患有垂体中间部功能减退症的马的证据。
BMC Vet Res. 2020 Sep 25;16(1):356. doi: 10.1186/s12917-020-02565-3.
7
Pharmacokinetics and pharmacodynamics of pergolide mesylate after oral administration in horses with pituitary pars intermedia dysfunction.甲磺酸培高利特在患有垂体中叶功能减退的马中经口给药后的药代动力学和药效学。
Domest Anim Endocrinol. 2019 Jul;68:135-141. doi: 10.1016/j.domaniend.2019.01.008. Epub 2019 Feb 8.
8
Fecal strongyle egg counts in horses with suspected pre-clinical pituitary pars intermedia dysfunction before and after treatment with pergolide.疑似临床前垂体中间叶功能障碍的马匹在培高利特治疗前后的粪便圆线虫卵计数。
Vet J. 2018 May;235:60-62. doi: 10.1016/j.tvjl.2018.03.007. Epub 2018 Mar 23.
9
Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.脑垂体中叶机能减退症和 Prascend(培高利特片剂)对马的内分泌和免疫功能的影响。
Domest Anim Endocrinol. 2021 Jan;74:106531. doi: 10.1016/j.domaniend.2020.106531. Epub 2020 Jul 29.
10
Recommendations from the Australian and New Zealand Equine Endocrine Group and the interpretation of plasma endogenous ACTH concentrations for the diagnosis of pituitary pars intermedia dysfunction (PPID).澳大利亚和新西兰马内分泌组的建议以及血浆内源性促肾上腺皮质激素(ACTH)浓度在垂体中间部功能障碍(PPID)诊断中的解读
Aust Vet J. 2018 Sep;96(9):317-318. doi: 10.1111/avj.12743.

引用本文的文献

1
Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction.对长效卡麦角林在马垂体中间部功能障碍管理中的应用进行回顾性评估。
Front Vet Sci. 2024 Mar 6;11:1332337. doi: 10.3389/fvets.2024.1332337. eCollection 2024.
2
A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies.胰高血糖素样肽-1 受体拮抗剂可降低马对血糖餐的胰岛素反应。
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad389.
3
Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID).
七匹向垂体中间叶功能障碍(PPID)转变的马匹临床体征和促肾上腺皮质激素(ACTH)浓度的前瞻性病例系列研究
Vet Sci. 2022 Oct 17;9(10):572. doi: 10.3390/vetsci9100572.
4
Pituitary Pars Intermedia Dysfunction (PPID) in Horses.马垂体中间叶功能障碍(PPID)
Vet Sci. 2022 Oct 10;9(10):556. doi: 10.3390/vetsci9100556.
5
Can Endocrine Dysfunction Be Reliably Tested in Aged Horses That Are Experiencing Pain?能否在遭受疼痛的老龄马匹中可靠地检测内分泌功能障碍?
Animals (Basel). 2020 Aug 14;10(8):1426. doi: 10.3390/ani10081426.